Genetically modified canola line NS-B50027-4 and its seeds from inbreeding.

The genetically modified canola line NS-B50027-4 addresses the need for a sustainable source of LC-ω3 fatty acids by producing seeds with high DHA content, suitable for both human consumption and aquaculture.

JP2026086457APending Publication Date: 2026-05-26NUSEED NUTRITIONAL AUSTRALIA PTY LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
NUSEED NUTRITIONAL AUSTRALIA PTY LTD
Filing Date
2026-01-16
Publication Date
2026-05-26

AI Technical Summary

Technical Problem

There is a need for a sustainable and commercially viable source of canola that produces long-chain omega-3 (LC-ω3) fatty acids, such as docosahexaenoic acid (DHA), which are currently obtained primarily from marine sources, and a need for canola strains that can grow as a cash crop with homogeneous, isozygous, and redifferentiable traits.

Method used

A genetically modified canola line, NS-B50027-4, is developed through genetic engineering and breeding to produce seeds with favorable levels of ω3 and LC-ω3 fatty acids, particularly DHA, achieving high DHA content comparable to wild fish oils.

Benefits of technology

The genetically modified canola line NS-B50027-4 provides seeds with significantly higher DHA content than conventional canola varieties, offering a ground-based system for producing LC-ω3 fatty acids suitable for human consumption and aquaculture.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026086457000001_ABST
    Figure 2026086457000001_ABST
Patent Text Reader

Abstract

We provide canola seeds that can be grown as a sustainable crop. [Solution] Seeds of the inbreeding canola line NS-B50027-4 are provided, and representative seeds of the said inbreeding canola line are deposited under ATCC accession number PTA-123186.
Need to check novelty before this filing date? Find Prior Art